Amgen
Tracked across 4 events · 40 articles · First seen Feb 05, 2026 · Last active Apr 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Howard Y. Chang, Chief Scientific Officer of Amgen, will speak at BioAsia 2026 on AI-powered biology for target discovery and precision medicine.
Feb 05, 2026 · 7 articles
Tech
Amgen is collaborating with OpenAI to deploy OpenAI===GPT-Rosalind across its research workflows. This partnership allows Amgen to apply advanced AI tools to its drug development processes, potentially enhancing precision and efficiency.
Apr 16, 2026 · 17 articles
Business
Dr. Howard Y. Chang, Chief Scientific Officer and SVP Global Research at Amgen, delivered a keynote address on advanced research and next-generation therapies.
Feb 16, 2026 · 9 articles
Business
Rajani Dinavahi spent seven years at Amgen, contributing to global development programs and regulatory filings.
Apr 01, 2026 · 7 articles
70
Amgen collaborating with OpenAI OpenAIOpenAI Launches...
70
Amgen collaborated on the launch of GPT-Rosalind OpenAIOpenAI Launches...
Howard Y. Chang
Chief Scientific Officer
↔
Amgen
Howard Y. Chang is the Chief Scientific Officer of Amgen.
NEWSDESK
Track Amgen live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard